The answer is "Never." Gene can't apply to the CFDA. According to the SEC filings, the Chinese "partner" is going to handle everything, including Trials.
So a better question is: did the Chinese company even start Trials yet? If so, when are results expected? And are they submitting as a Class III or Class II?
An even better question: Why did the Chinese company stop making payments after the initial $750,000?
I guess the good news is: at least Gene got $750,000.